S
Sionna Therapeutics, Inc. (SION)
NGM – Real vaqt narxi. Valyuta: USD
42.18
-0.59 (-1.38%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
42.18
-0.00 (-0.00%)
Bozordan keyin: Jun 26, 2026, 4:36 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
42.18
-0.59 (-1.38%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
42.18
-0.00 (-0.00%)
Bozordan keyin: Jun 26, 2026, 4:36 PM EDT
Sionna Therapeutics, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, fibroz kistalar (FK) davolash uchun dori vositalarini tadqiq qiladi va ishlab chiqadi. U fibroz kistalar transmembran o'tkazuvchanlik regulyatori (CFTR) ning transmembran domen 1 (TMD1) ga yo'naltirilgan galikafator (SION-2222) ishlab chiqadi, u 2-bosqich sinovlarini yakunlagan; navokafator (SION-3067), potentsiator, u 2-bosqich sinovlarini yakunlagan; SION-109, hujayra ichidagi loop 4 ga yo'naltirilgan CFTR korrektori, u 1-bosqich sinovlarini yakunlagan; SION-2851, TMD1 ga yo'naltirilgan CFTR korrektori, u 1-bosqich sinovlarini yakunlagan; SION-451, bu 1-bosqich sinovlarida bo'lgan nukleotid-bog'lanish domeni 1 stabilizatori; va SION-719, bu 2a-bosqichli kontseptual isbot sinovida bo'lgan nukleotid-bog'lanish domeni 1 stabilizatori. Kompaniya ilgari Sling Therapeutics, Inc. nomi bilan tanilgan va 2021-yil iyul oyida Sionna Therapeutics, Inc. nomiga o'zgargan. Sionna Therapeutics, Inc. 2019-yilda ro'yxatdan o'tgan va shtab-kvartirasi Waltham, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Greg Hurlbut Ph.D. | Co-Founder & Senior VP of Discovery Research |
| Dr. Mark Munson Ph.D. | Co-founder & Senior VP of Medicinal Chemistry |
| Mr. Andy Chu | Vice President of Information & Technology |
| Mr. Michael Cloonan M.B.A. | President, CEO & Director |
| Ms. Caroline Stark Beer M.B.A. | Chief Business Officer |
| Ms. Elena H. Ridloff C.F.A. | Chief Financial Officer |
| Ms. Jennifer Fitzpatrick J.D. | Chief Legal Officer |
| Ms. Meghan Bagshaw | Vice President of Programs, Portfolio & Operations |
| Ms. Sarah J. Spencer | Vice President of Corporate Communications |
| Ms. Vanya Sagar | Chief People Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-18 | 8-K | sion-20260617.htm |
| 2026-05-12 | 8-K | sion-20260512.htm |
| 2026-05-12 | 10-Q | sionna-20260331.htm |
| 2026-04-27 | DEFA14A | a2026sionnatherapeuticsinc.htm |
| 2026-04-27 | ARS | ars.htm |
| 2026-03-02 | S-3ASR | d16683ds3asr.htm |
| 2026-03-02 | 8-K | sion-20260302.htm |
| 2026-03-02 | 10-K | sionna-20251231.htm |
| 2025-11-05 | 8-K | sion-20251105.htm |
| 2025-11-05 | 10-Q | sionna-20250930.htm |